Literature DB >> 7308991

Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver disease.

L L Andres, V K Sawhney, G H Scullard, J L Smith, T C Merigan, W S Robinson, P B Gregory.   

Abstract

Fifty patients with chronic HBs antigenemia and Dane particle-associated DNA polymerase and HBeAg in their serum were contrasted to 46 HBsAg positive patients who had neither serum DNA polymerase or HBeAg. The time from acute onset and the duration of antigenemia were longer in patients who were DNA polymerase and HBeAg negative than in those who had both serum markers. Cirrhosis, hypoalbuminemia, and sequelae of chronic liver disease were more common in DNA polymerase, HBeAg negative patients than in those who were positive. These findings are consistent with the hypothesis that active viral replication is an early, albeit prolonged stage in the development of advanced HBsAg-associated liver disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308991     DOI: 10.1002/hep.1840010604

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  A mouse model for HBV immunotolerance and immunotherapy.

Authors:  Dan Yang; Longchao Liu; Danming Zhu; Hua Peng; Lishan Su; Yang-Xin Fu; Liguo Zhang
Journal:  Cell Mol Immunol       Date:  2013-09-30       Impact factor: 11.530

2.  [Anti-HBc IgM in acute and chronic hepatitis B virus infection].

Authors:  K Gmelin; L Theilmann; G Hasche; H Will; P Czygan; H W Doerr; B Kommerell
Journal:  Klin Wochenschr       Date:  1984-09-03

3.  A newly identified hepatitis B type virus in tree squirrels.

Authors:  M A Feitelson; I Millman; T Halbherr; H Simmons; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases.

Authors:  S Kashiwagi; J Hayashi; H Ikematsu; H Nomura; W Kajiyama; T Shingu; K Hayashida; M Kaji
Journal:  Gastroenterol Jpn       Date:  1988-04

Review 5.  The use of interferon-alpha in virus infections.

Authors:  N B Finter; S Chapman; P Dowd; J M Johnston; V Manna; N Sarantis; N Sheron; G Scott; S Phua; P B Tatum
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.